Rubomycin - analogs
Components: Daunorubicin |
|||||||||
Pharmgroups: Antitumor antibiotics || Anthracyclines and related compounds |
|||||||||
| Prices in pharmacies: — Instructions Rubomycin | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Paracetamol ✘ (incl) Tolperisone ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
| Similar | Complete analog ⓘ✘Analogues of the drug with completely identical active ingredients |
Prices in pharmacies |
| ≈100% | Negative 🔍 Daunorubicin-LANS | 1.8€ |
| ≈100% | Negative 🔍 Rubomycin hydrochloride | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 50% — Doxolem Dangerous 🔍 [Doxorubicin]
- 50% 3.5€ Adriblastina rapid dissolution Dangerous 🔍 [Doxorubicin]
- 50% 118€ Cosmegen Negative 🔍 [Dactinomycin]
- 49% — Episindan Negative 🔍 [Epirubicin]
- 49% — Никорубин Dangerous 🔍 [Doxorubicin]
- 49% 2.6-7.7€ Doxorubicin-LANS Dangerous 🔍 [Doxorubicin]
- 49% — Doxorubicin Lachema Dangerous 🔍 [Doxorubicin]
- 49% — Rastocin Dangerous 🔍 [Doxorubicin]
- 49% — Doxorubicin-Ferein Dangerous 🔍 [Doxorubicin]
- 49% 6.9€ Doxorubicin-Teva Dangerous 🔍 [Doxorubicin]
- 49% — Doxorubicin hydrochloride Dangerous 🔍 [Doxorubicin]
- 49% — Доксофос Dangerous 🔍 [Doxorubicin]
- 47% — Doxorubifer Dangerous 🔍 [Doxorubicin]
- 47% 970€ Caelyx Dangerous 🔍 [Doxorubicin]
- 47% 228€ Dactinomycin Negative 🔍 [Dactinomycin]
- 46% — Aknomid D Negative 🔍 [Dactinomycin]
- 46% 9.9€ Doxorubicin-Ebewe Dangerous 🔍 [Doxorubicin]
- 45% 2.6€ Doxorubicin Dangerous 🔍 [Doxorubicin]
- 45% — Adriblastina NovaMedica rapid dissolution Dangerous 🔍 [Doxorubicin]
- 45% — Doxorubicin-RONC Dangerous 🔍 [Doxorubicin]
- 45% — Doxorubicin-DEKO Dangerous 🔍 [Doxorubicin]
- 44% 11.7€ Farmorubicin rapid dissolution Negative 🔍 [Epirubicin]
- 44% — Farmorubicin Negative 🔍 [Epirubicin]
- 44% — Эпирубицин-РОНЦ Negative 🔍 [Epirubicin]
- 44% — Epirubicin Negative 🔍 [Epirubicin]
- 44% — Эпирубицин-Келун-Казфарм Negative 🔍 [Epirubicin]
- 44% 2.8-32.8€ Epirubicin-Ebewe Negative 🔍 [Epirubicin]
- 44% — Эпирубицин-Рус Negative 🔍 [Epirubicin]
- 44% — Epirubicin hydrochloride Negative 🔍 [Epirubicin]
- 44% 3.6€ Sindroxocin Dangerous 🔍 [Doxorubicin]
- 44% — Epilek Negative 🔍 [Epirubicin]
- 41% 15.7€ Bleocin Negative 🔍 [Bleomycin and more 1Bleomycin sulfate]
- 41% — Bleomycetin Negative 🔍 [Bleomycin]
- 41% — Bleomycetin hydrochloride Negative 🔍 [Bleomycin]
- 41% 12.9€ Vero-Bleomycin Negative 🔍 [Bleomycin]
- 40% 5.3-19.5€ Vero-Epirubicin Negative 🔍 [Epirubicin]
- 39% 44-80€ Rubide Negative 🔍 [Idarubicin]
- 37% 2.4€ Fytosid Negative 🔍 [Etoposide]
- 35% 13.6€ Cytarabine Negative 🔍 [Cytarabine]
- 35% — Мальтин Negative 🔍 [Bleomycin]
- 35% — Blenamax Negative 🔍 [Bleomycin]
- 35% — Idarubicin Negative 🔍 [Idarubicin]
- 35% 30€ Zavedos Negative 🔍 [Idarubicin]
- 35% — Dactinomycin solution for injections Negative 🔍 [Dactinomycin]
- 35% — Bleomycetin hydrochloride for injections Negative 🔍 [Bleomycin]
- 35% — Idalek Negative 🔍 [Idarubicin]
- 35% — Idarubicin hydrochloride Negative 🔍 [Idarubicin]
- 34% 23.4€ Mitoxantron-LANS Dangerous 🔍 [Mitoxantrone]
- 34% 5.6-9.2€ Alexan Negative 🔍 [Cytarabine]
- 34% 43.5-44€ Oncotrone Dangerous 🔍 [Mitoxantrone]
Learn more about the selection of analogues
- The drug has «Rubomycin» 2 full analogs, the cheapest - Daunorubicin-LANS (1.8€); 51 analog by action, the most similar - Adriblastina rapid dissolution (3.5€).
- Medical online service has selected the best substitutes for Rubomycin based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Rubomycin to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.